Companies: 10,795·Total market cap: $144.5T
Urologix, Inc.

Urologix, Inc.

ULGXOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2182
P/E Ratio
52W High$0.0126
52W Low$0.0001
Overview

Urologix, Inc.(ULGX)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ULGX · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.22ulgx eps ttm · ulgx earnings per shareEarnings history
PE Ratio (TTM)ulgx pe ratio ttm · ulgx price to earningsPE Ratio deep dive
Revenue (TTM)$12.2Mulgx revenue ttm · ulgx annual revenueFull revenue history
Dividend Yield不分红does ulgx pay dividends · ulgx dividend yieldDividend history
Shares Outstanding21.2Mulgx shares outstanding · ulgx floatShares outstanding history
Next EarningsTBAulgx earnings date · ulgx next earningsEarnings history

财务快照

完整财报
FY 2014Revenue$14.2M▼ 14.20% YoY
201220132014
urologix, inc. revenue · ulgx revenue 2014
FY 2014Net Income-$7.6M▼ 77.26% YoY
201220132014
urologix, inc. net income · ulgx profit 2014
FY 2014EPS$-0.36▼ 71.43% YoY
201220132014
ulgx eps · urologix, inc. earnings per share 2014
TTM:Revenue: $12.2MNet Income: -$4.7MEPS: $-0.22View income statement →

股票表现

完整历史
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-98.72%

关于 Urologix, Inc.

CEOBryon Merade
IPO DateMay 30, 1996
Employees61
CountryUS

Urologix, Inc. Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the…

what is urologix, inc. · ulgx stock overview · urologix, inc. company profile · who is urologix, inc. ceo · ulgx OTC · urologix, inc. headquarters · urologix, inc. business segments

关于股票概览与关键数据

Urologix, Inc.(ULGX)是 Medical - Devices 行业的 Healthcare 类公司,于 May 30, 1996 在 OTC 上市。截至最近交易日,ULGX 股价为 $0.00,市值约为 $2,182。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。

2014 财年 Urologix, Inc. 营收 $14.2M。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Urologix, Inc.(ULGX)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $0.01。

ULGX 最新股价ULGX quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 8, 2026本内容不构成投资建议